GateHouse Bio (fka sRNAlytics)
An RNA therapeutic company
GateHouse Bio (fka sRNAlytics) is a company in biopharma based in United States, founded in 2016.
Profile
Gatehouse Bio is a biotech company developing RNA therapeutics using AI that harnesses the power of small RNA. Their platform discovers disease-associated mutations and designs therapeutics to counteract their effect.
As a business in biopharma, GateHouse Bio (fka sRNAlytics) is listed here with the public details available about it.
Its base of operations is United States.
Directory data places it at the SOSV portfolio company stage.
Its team size is recorded as 11-50 employees.
It has disclosed roughly $2.4M in funding.
| Sector | Biopharma |
|---|---|
| Country | United States |
| Founded | 2016 |
| Employees | 11-50 |
| Stage | SOSV portfolio company |
| Total funding | $2,400,000 |
Website: gatehousebio.com
Contact details and direct channels are available to signed-in members.
Create a free account
Create a free account